This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Barber, D L Articles by D'Andrea, A D Search for Related Content PubMed PubMed Citation Articles by Barber, D L Articles by D'Andrea, A D

A dominant negative erythropoietin (EPO) receptor inhibits EPO-dependent growth and blocks F-gp55-dependent transformation.

Division of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115.

ABSTRACT

The erythropoietin receptor (EPO-R), a member of the cytokine receptor superfamily, can be activated to signal cell growth by binding either EPO or F-gp55, the Friend spleen focus-forming virus glycoprotein. Activation by F-gp55 results in constitutive EPO-R signalling and the first stage of Friend virus-induced erythroleukemia. We have generated a truncated form of the EPO-R polypeptide [EPO-R(T)] which lacks the critical cytoplasmic signal-transducing domain of the EPO-R required for EPO- or F-gp55-induced cell growth. EPO-R(T) specifically inhibited the EPO-dependent growth of EPO-R-expressing Ba/F3 cells without changing the interleukin-3-dependent growth of these cells. In addition, Ba/F3 cells that coexpressed wild-type EPO-R and EPO-R(T) were resistant to transformation by F-gp55 despite efficient expression of the F-gp55 transforming oncoprotein in infected cells. EPO-R(T) inhibited the EPO-dependent tyrosine phosphorylation of wild-type EPO-R, the tyrosine kinase (JAK2), and the SH2 adaptor protein (Shc). In conclusion, the EPO-R(T) polypeptide is a dominant negative polypeptide which specifically interferes with the early stages of EPO-R-mediated signal transduction and which prevents Friend virus transformation of erythroblasts.

This article has been cited by other articles:

• Lu, X., Huang, L. J.-S., Lodish, H. F. (2008). Dimerization by a Cytokine Receptor Is Necessary for Constitutive Activation of JAK2V617F. J. Biol. Chem. 283: 5258-5266 [Abstract] [Full Text]  
• Haq, R., Halupa, A., Beattie, B. K., Mason, J. M., Zanke, B. W., Barber, D. L. (2002). Regulation of Erythropoietin-induced STAT Serine Phosphorylation by Distinct Mitogen-activated Protein Kinases. J. Biol. Chem. 277: 17359-17366 [Abstract] [Full Text]  
• Chen, C., Sytkowski, A. J. (2001). Erythropoietin Activates Two Distinct Signaling Pathways Required for the Initiation and the Elongation of c-myc. J. Biol. Chem. 276: 38518-38526 [Abstract] [Full Text]  
• Barber, D. L., Beattie, B. K., Mason, J. M., Nguyen, M. H.-H., Yoakim, M., Neel, B. G., D'Andrea, A. D., Frank, D. A. (2001). A common epitope is shared by activated signal transducer and activator of transcription-5 (STAT5) and the phosphorylated erythropoietin receptor: implications for the docking model of STAT activation. Blood 97: 2230-2237 [Abstract] [Full Text]  
• Mason, J. M., Beattie, B. K., Liu, Q., Dumont, D. J., Barber, D. L. (2000). The SH2 Inositol 5-Phosphatase Ship1 Is Recruited in an SH2-dependent Manner to the Erythropoietin Receptor. J. Biol. Chem. 275: 4398-4406 [Abstract] [Full Text]  
• Zhan, H., Liu, B., Reid, S. W., Aoki, K. H., Li, C., Syed, R. S., Karkaria, C., Koe, G., Sitney, K., Hayenga, K., Mistry, F., Savel, L., Dreyer, M., Katz, B. A., Schreurs, J., Matthews, D. J., Cheetham, J. C., Egrie, J., Giebel, L. B., Stroud, R. M. (1999). Engineering a soluble extracellular erythropoietin receptor (EPObp) in Pichia pastoris to eliminate microheterogeneity, and its complex with erythropoietin. Protein Eng Des Sel 12: 505-513 [Abstract] [Full Text]  
• Watowich, S. S., Liu, K. D., Xie, X., Lai, S. Y., Mikami, A., Longmore, G. D., Goldsmith, M. A. (1999). Oligomerization and Scaffolding Functions of the Erythropoietin Receptor Cytoplasmic Tail. J. Biol. Chem. 274: 5415-5421 [Abstract] [Full Text]  
• Okuda, K., D'Andrea, A., Van Etten, R.A., Griffin, J.D. (1998). The C-Terminus of c-Abl Is Required for Proliferation and Viability Signaling in a c-Abl/Erythropoietin Receptor Fusion Protein. Blood 92: 3848-3856 [Abstract] [Full Text]  
• Muszynski, K. W., Ohashi, T., Hanson, C., Ruscetti, S. K. (1998). Both the Polycythemia- and Anemia-Inducing Strains of Friend Spleen Focus-Forming Virus Induce Constitutive Activation of the Raf-1/Mitogen-Activated Protein Kinase Signal Transduction Pathway. J. Virol. 72: 919-925 [Abstract] [Full Text]  
• Perrot-Applanat, M., Gualillo, O., Pezet, A., Vincent, V., Edery, M., Kelly, P. A. (1997). Dominant Negative and Cooperative Effects of Mutant Forms of Prolactin Receptor. Mol. Endocrinol. 11: 1020-1032 [Abstract] [Full Text]  
• Barber, D. L., Mason, J. M., Fukazawa, T., Reedquist, K. A., Druker, B. J., Band, H., D'Andrea, A. D. (1997). Erythropoietin and Interleukin-3 Activate Tyrosine Phosphorylation of CBL and Association With CRK Adaptor Proteins. Blood 89: 3166-3174 [Abstract] [Full Text]  
• Gonda, T. J., D'Andrea, R. J. (1997). Activating Mutations in Cytokine Receptors: Implications for Receptor Function and Role in Disease. Blood 89: 355-369 [Full Text]  
• Schneider, H., Chaovapong, W., Matthews, D. J., Karkaria, C., Cass, R. T., Zhan, H., Boyle, M., Lorenzini, T., Elliott, S. G., Giebel, L. B. (1997). Homodimerization of Erythropoietin Receptor by a Bivalent Monoclonal Antibody Triggers Cell Proliferation and Differentiation of Erythroid Precursors. Blood 89: 473-482 [Abstract] [Full Text]  
• Barber, D. L., Corless, C. N., Xia, K., Roberts, T. M., D'Andrea, A. D. (1997). Erythropoietin Activates Raf1 by an Shc-Independent Pathway in CTLL-EPO-R Cells. Blood 89: 55-64 [Abstract] [Full Text]  
• Nguyen, M. H.-H., Ho, J. M.-Y., Beattie, B. K., Barber, D. L. (2001). TEL-JAK2 Mediates Constitutive Activation of the Phosphatidylinositol 3'-Kinase/Protein Kinase B Signaling Pathway. J. Biol. Chem. 276: 32704-32713 [Abstract] [Full Text]